Welcome to our dedicated page for Black Bird Biotech news (Ticker: BBBT), a resource for investors and traders seeking the latest updates and insights on Black Bird Biotech stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Black Bird Biotech's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Black Bird Biotech's position in the market.
Black Bird Biotech (OTC PINK: BBBT) has announced a new distribution agreement with Green Search, Inc., a distributor focused on unique agricultural solutions in the U.S., Canada, The Netherlands, and Brazil. This partnership is expected to enhance the reach of MiteXstream, an EPA-registered biopesticide designed to eliminate pests like spider mites while being safe for honey bees. The collaboration aims to leverage Green Search's international presence as Black Bird Biotech moves towards global registration efforts for its innovative products.
Black Bird Biotech (OTC PINK:BBBT) announced securing full-page ad space in all 2023 issues of Cannabis Now Magazine, enhancing visibility for its MiteXstream™ biopesticide. This extensive advertising package includes premium placement, sponsored content, and social media promotion, aimed at boosting brand awareness within the cannabis industry. The agreement follows a positive relationship established at MJBizCon 2022 and complements an existing collaboration with XCPCNL Business Services for direct sales expertise.
Black Bird Biotech has partnered with XCPCNL Business Services Corporation to enhance sales for its MiteXstream biopesticide targeting the cannabis industry. This collaboration aims to leverage XCPCNL's expertise in brand awareness and direct sales, particularly in B2B markets. Company President Fabian Deneault expressed confidence in XCPCNL's capabilities to support upcoming distributor engagements. MiteXstream is noted for its safety, being honey bee-friendly and compliant with state cannabis testing.
Black Bird Biotech, Inc. (OTC: BBBT) provided a shareholder update highlighting its biopesticide, MiteXstream, which received positive attention at the August 2022 Cannabis Conference. The product is now available at Ace Hardware in Montana, with plans for a national rollout in Spring 2023. Sales through Amazon average 120 units monthly. The company is exploring acquisition opportunities in the cannabis sector to bolster its operations. A search for a qualified CEO is underway, emphasizing the importance of passion for MiteXstream. Investing in strategic growth is prioritized.
Black Bird Biotech, OTC:BBBT, announced testing of its MiteXstreamTM biopesticide to assess its potential for enhancing plant nutrient absorption and production capabilities. The trials aim to demonstrate if treated plants show increased growth and yield in crops like peppers and cannabis. The company cites a growing market for biopesticides, supported by a 3.4% CAGR projected for the global fertilizer sector, underscoring the potential for MiteXstreamTM to leverage market opportunities.
Black Bird Biotech (OTC PINK: BBBT) has announced a distribution agreement with Chicago-based Beyond Das Skin for its Grizzly Creek Naturals CBD product line. Beyond Das Skin, with over 40 years in luxury spa product distribution, aims to enhance its catalog with this partnership. The global CBD market was valued at $12.8 billion in 2021 and is projected to grow at a CAGR of 21.7% from 2022 to 2028, driven by health benefits and pet wellness. This collaboration underscores BBBT's strategy to capitalize on the expanding CBD market.
Black Bird Biotech, Inc. (OTC PINK:BBBT) announced plans to exchange nearly 124 million shares of its common stock for Series A Preferred Stock, representing approximately 36% of outstanding shares. This strategic move aims to minimize shareholder dilution and reinforce the company's long-term commitment to MiteXstream, its plant-based biopesticide. The exchange is expected to conclude by August 19, 2022. Recent sales data underscores growing customer satisfaction.
Black Bird Biotech (OTC:BBBT) will showcase its biopesticide, MiteXstream, at the Illinois State Fair from August 11-21 and the Du Quoin State Fair from August 26-September 5, 2022. Additionally, it will participate in the Cannabis Conference 2022 in Las Vegas from August 23-25. The marketing strategy aims to reach over 100,000 farmers amidst growing spider mite challenges. The company emphasizes MiteXstream's unique selling point as a non-toxic pesticide that can be used up to harvest day, appealing to various agricultural sectors.
Black Bird Biotech, Inc. (OTC PINK: BBBT) is set to launch an affiliate sales program for its Grizzly Creek Naturals CBD product line in early August 2022. The company is also negotiating national distribution agreements aimed to finalize around the same time. President Fabian Deneault noted a surge in interest for their CBD offerings, which are manufactured with minimal ingredients. The CBD market, valued at $12.8 billion in 2021, is projected to grow at a CAGR of 21.7% through 2028, driven by increasing health awareness and pet wellness trends.
FAQ
What is the current stock price of Black Bird Biotech (BBBT)?
What is the market cap of Black Bird Biotech (BBBT)?
